The Oncology Center of Excellence (OCE) at the FDA has developed more than 300 projects and programs aimed at promoting the progress and regulation of medical products for cancer patients. Within this vast array of projects, there is a specific group that plays a crucial role in ensuring that oncology clinical trials are inclusive and accessible to patients. This resource provides an overview of Project Equity, Project Silver, and Project Orbis, their objectives, and how they can be implemented in your program.